Still, in line with the cancer-promoting activities attributed to DDAH1 [40,41,42,43] and DDAH2 [44], the expression ratio (tumor-to-adjacent) of DDAH2 tended to increase with cancer advancement, reflecting lymph node involvement. The gene discussed is DDAH2; the disease is cancer.